Medical Science News

RSS

Moderna vaccine reduces viral spread by at least 60 percent, finds study

An interesting new study by researchers at Harvard T.H. Chan School of Public Health in the U.S. suggests that the currently used Moderna vaccine reduces viral shedding by about 60%.

2 Mar 2021

CN Bio awarded Innovate UK grant to develop single and multi-organ models for COVID-19 research

CN Bio today announced it has received a grant from Innovate UK to develop human-relevant MPS to advance investigations into SARS-CoV-2 infection.

From CN Bio 2 Mar 2021

Studies reveal the promise of newly engineered bispecific antibodies against tumor cells

Three studies - one each in Science, Science Translational Medicine, and Science Immunology - reveal the promise of newly engineered bispecific antibodies, including by demonstrating their power against previously inaccessible tumor cell targets for the first time, in two cases.

2 Mar 2021

Experimental therapy delays viral rebound in SHIV-infected macaques

A recent preclinical study by U.S. Military HIV Research Program (MHRP) researchers showed that an experimental therapy combining a TLR7 agonist and two broadly neutralizing antibodies delayed viral rebound in SHIV-infected macaques after antiretroviral therapy (ART) interruption.

2 Mar 2021

New injectable hydrogel could heal cardiac tissue after heart attack

Researchers at CÚRAM, the SFI Research Centre for Medical Devices based at National University of Ireland Galway, and BIOFORGE Lab, at the University of Valladolid in Spain, have developed an injectable hydrogel that could help repair and prevent further damage to the heart muscle after a heart attack.

2 Mar 2021

Study reveals the effect of digital devices on children's cognitive, socio-emotional development

What can you see in this picture (next to the article)? Say what comes to your mind immediately! If you said „star", you focus rather on the details, if you said „sun", then rather on the global pattern.

2 Mar 2021

Researchers explore early stages of ribosome formation to identify new targets for antibiotics

Ribosome formation is viewed as a promising potential target for new antibacterial agents. Researchers from Charité - Universitätsmedizin Berlin have gained new insights into this multifaceted process.

2 Mar 2021

Unique nanoparticles can package and deliver gene-editing machinery to the liver

The genome editing technology CRISPR has emerged as a powerful new tool that can change the way we treat disease. The challenge when altering the genetics of our cells, however, is how to do it safely, effectively, and specifically targeted to the gene, tissue and organ that needs treatment.

2 Mar 2021

Study reveals presence of glial plasticity, offers future therapeutic strategy for epilepsy

Tohoku University scientists and their colleagues in Germany have revealed that a first-time exposure to only a brief period of brain hyperactivity resulted in an acute breakdown of the inter-cellular network of glial cells.

2 Mar 2021

UTMB researchers pioneer a new way to study frustration as a factor in substance use disorders

A team from The University of Texas Medical Branch at Galveston (UTMB) focused on drug addiction research have pioneered a new way to study frustration as a factor in substance use disorders.

1 Mar 2021

New vaccination strategy could eliminate the bacteria that cause UTIs

Anyone who has ever developed a urinary tract infection (UTI) knows that it can be painful, pesky and persistent. UTIs have a high recurrence rate and primarily afflict women -- as many as 50% of women will experience at least one UTI during their lifetime.

1 Mar 2021

Lung cancer cells activate different signaling pathways in response to KRAS inhibitors

Genetic alterations of the KRAS gene are some of the most common mutations in lung cancer patients, but unfortunately these patients have few effective treatment options.

1 Mar 2021

Study: Highly efficient and balanced immune response key to avoiding COVID-19 symptoms

By analyzing blood samples from individuals infected with SARS-CoV-2, researchers in Singapore have begun to unpack the different responses by the body's T cells that determine whether or not an individual develops COVID-19.

1 Mar 2021

Toxicological assessment of hemp-containing foods

In order to avoid the occurrence of such effects, the Federal Institute for Health Protection of Consumers and Veterinary Medicine (BgVV) recommended guidance values for maximum THC levels in various food groups in 2000.

1 Mar 2021

Study could offer a new way to treat Type 1 and Type 2 diabetes

Blocking cell receptors for glucagon, the counter-hormone to insulin, cured mouse models of diabetes by converting glucagon-producing cells into insulin producers instead, a team led by UT Southwestern reports in a new study.

1 Mar 2021

New technique uncovers the tricks used by cancer cells to evade immunotherapies

By harnessing the immune system against cancer, immunotherapies have revolutionized the way some types of cancer are treated. But most patients--across cancer types--do not respond, and in most cases, scientists are at a loss as to why.

1 Mar 2021

A region within GLI1 gene could potentially be targeted as cancer treatment

Scientists from the Stanley Manne Children's Research Institute at Ann & Robert H. Lurie Children's Hospital of Chicago found that a region within the DNA of the cancer-promoting GLI1 gene is directly responsible for regulating this gene's expression.

1 Mar 2021

NYU Oral Cancer Center receives $3.1 million grant to explore the interplay between nerves and cancer

NYU Oral Cancer Center has been awarded a five-year, $3.1 million grant (R01 CA231396) by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH).

1 Mar 2021

Researchers develop mutant gene-targeted immunotherapy approach to fight cancers

A novel targeted immunotherapy approach developed by researchers at the Ludwig Center, the Lustgarten Laboratory, and Bloomberg~Kimmel Institute for Cancer Immunotherapy at the Johns Hopkins Kimmel Cancer Center employs new antibodies against genetically altered proteins to target cancers.

1 Mar 2021

A backbone free energy study of SARS-CoV-2 variants of concern

A recent study by scientist Robert Penner at the Institut des Hautes Études Scientifiques in France utilizes free energy calculations to predict effective antiviral targets that are highly conserved, surface-accessible for interaction, and resistant to mutation.

1 Mar 2021

Medical Science News

Moderna vaccine reduces viral spread by at least 60 percent, finds study

CN Bio awarded Innovate UK grant to develop single and multi-organ models for COVID-19 research

Studies reveal the promise of newly engineered bispecific antibodies against tumor cells

Experimental therapy delays viral rebound in SHIV-infected macaques

New injectable hydrogel could heal cardiac tissue after heart attack

Study reveals the effect of digital devices on children's cognitive, socio-emotional development

Researchers explore early stages of ribosome formation to identify new targets for antibiotics

Unique nanoparticles can package and deliver gene-editing machinery to the liver

Study reveals presence of glial plasticity, offers future therapeutic strategy for epilepsy

UTMB researchers pioneer a new way to study frustration as a factor in substance use disorders

New vaccination strategy could eliminate the bacteria that cause UTIs

Lung cancer cells activate different signaling pathways in response to KRAS inhibitors

Study: Highly efficient and balanced immune response key to avoiding COVID-19 symptoms

Toxicological assessment of hemp-containing foods

Study could offer a new way to treat Type 1 and Type 2 diabetes

New technique uncovers the tricks used by cancer cells to evade immunotherapies

A region within GLI1 gene could potentially be targeted as cancer treatment

NYU Oral Cancer Center receives $3.1 million grant to explore the interplay between nerves and cancer

Researchers develop mutant gene-targeted immunotherapy approach to fight cancers

A backbone free energy study of SARS-CoV-2 variants of concern

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Latest News